Digital Innovation in Schizophrenia Assessment: Integration of AI-Powered Language Analysis and Neural Biomarkers for Enhanced Psychiatric Diagnosis. A Multi-National Validation Study of Quantitative Diagnostic Tools in Poland, Latvia, and Portugal" DISA-LNT (Digital Innovation in Schizophrenia Assessment - Language Neural Technology)

This innovative healthcare technology project integrates AI-powered language analysis with neural biomarkers to create a comprehensive schizophrenia assessment tool. The collaboration between Psychomeasure and BrainTrip, supported by leading institutions in Poland, Latvia, and Portugal, focuses on developing a digital solution that combines EEG analysis with advanced language processing. The project aims to address current challenges in mental health diagnosis through objective, quantitative assessment methods. Through nine carefully structured work packages, the initiative covers everything from technical development and clinical validation to ethical compliance and commercial implementation. Key features include real-time analysis capabilities, multi-language support, and integration with existing clinical workflows. The project's potential impact extends beyond immediate clinical applications to influence future healthcare delivery models, drug discovery, and personalized medicine approaches.